Matt OBrien
Stock Analyst at Piper Sandler
(3.01)
# 1,472
Out of 5,090 analysts
8
Total ratings
75%
Success rate
38.14%
Average return
Main Sectors:
Stocks Rated by Matt OBrien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Overweight | $38 | $27.53 | +38.03% | 1 | Sep 2, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $55 → $62 | $83.43 | -25.69% | 6 | Oct 29, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $70 → $90 | $20.92 | +330.21% | 1 | Feb 25, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $27.53
Upside: +38.03%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55 → $62
Current: $83.43
Upside: -25.69%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70 → $90
Current: $20.92
Upside: +330.21%